Document is current
Any future updates will be listed below
-
Authors
Xia, Ziyun
Yu, Minzhi
Liu, Yayuan
Yuan, Wenmin
Wang, Yan
Xu, Xiaoming
Bae, Jungeun
Schwendeman, Anna https://orcid.org/0000-0002-8023-8080
-
Funding
Funding for this research was provided by:
U.S. Food and Drug Administration (75F40120C00127)
- License Information
-
More Information
Article History
Received: 3 October 2023
Accepted: 22 December 2023
First Online: 11 January 2024
Declarations
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Anna Schwendeman reports financial support was provided by US Food and Drug Administration. Anna Schwendeman reports a relationship with EVOQ Therapeutics that includes: board membership, consulting or advisory, equity or stocks, and funding grants.
